more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$82.26 USD

-1.49 (-1.78%)

Updated May 16, 2024 04:00 PM ET

After-Market: $82.24 -0.02 (-0.02%) 6:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

Bottom 41% (147 out of 250)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now

by Zacks Equity Research Published on May 02,2019

Merit Medical (MMSI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

MMSINegative Net Change

Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates

by Zacks Equity Research Published on April 24,2019

Higher revenues, solid segmental performance and strong adjusted gross margins benefit Merit Medical's (MMSI) Q1 earnings. However, higher expenses remain a concern.

XRAY or MMSI: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on April 23,2019

XRAY vs. MMSI: Which Stock Is the Better Value Option?

Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research Published on April 16,2019

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MMSINegative Net Change

Merit Medical (MMSI) Up 5.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research Published on March 28,2019

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MMSINegative Net Change

Merit Medical (MMSI) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research Published on March 14,2019

Merit Medical (MMSI) delivered earnings and revenue surprises of 6.67% and 1.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

MMSINegative Net Change

Here's Why Investors Should Bet on Merit Medical (MMSI) Now

by Zacks Equity Research Published on March 08,2019

Merit Medical's (MMSI) upbeat guidance for 2019 is indicative of the company's brighter prospects.

Top Ranked Growth Stocks to Buy for March 7th

by Zacks Equity Research Published on March 07,2019

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 7th

Here's Why You Should Hold Becton, Dickinson Stock for Now

by Zacks Equity Research Published on March 05,2019

Becton, Dickinson's (BDX) MAX enteric viral panel receives FDA clearance.

medical

DENTSPLY's (XRAY) Preliminary Q4 Results Cheer Investors

by Zacks Equity Research Published on March 04,2019

DENTSPLY (XRAY) expects to see solid performance in Europe and the rest of the world.

medical

Here's Why You Should Buy Varian Medical (VAR) Stock Now

by Zacks Equity Research Published on March 01,2019

Buoyed by a strong first quarter, Varian Medical (VAR) has kept its fiscal 2019 guidance intact.

medical

Merit Medical (MMSI) Q4 Earnings & Revenues Surpass Estimates

by Zacks Equity Research Published on February 28,2019

Merit Medical (MMSI) registers solid expansion in adjusted gross margins in fourth-quarter 2018.

earnings

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

by Zacks Equity Research Published on February 22,2019

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

airlines

Worried About Rate Hikes? Buy These 5 Low Leverage Stocks

by Zacks Equity Research Published on February 21,2019

If a company is highly leveraged, investors will not add it to their portfolios. A high degree of financial leverage means high interest payments, which may affect a company's bottom line.

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Steelcase, Southwest and EMCOR

by Zacks Equity Research Published on February 07,2019

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Steelcase, Southwest and EMCOR

airlines

Bet on These 5 Low Leverage Stocks to Escape Debt Traps

by Zacks Equity Research Published on February 06,2019

With the Q4 earnings season in full swing currently, investors must be targeting companies with solid earnings growth projections. But they must consider their debt level first.